Trial intelligence / Profile preview

JATENZO Adrenal Safety Study in Hypogonadal Men

NCT06385509Phase 4Completed

Sponsor
Tolmar
Start
Jul 2024
Primary completion
Nov 2025
Modality
Hormone, Biologic
Countries
1
01

Overview

A Phase 4 trial of testosterone undecanoate in Hypogonadism, sponsored by Tolmar. Started Jul 2024; status: completed.

02

Drugs

testosterone undecanoate
03

Conditions

Hypogonadism

Beyond the preview

Go deeper on NCT06385509.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06385509.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call